Impact of sacubitril –valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO‐SAS study design

ConclusionsIn the context of the SERVE‐HF study, physicians are waiting for new trials and alternative therapies. We sought to assess in the ENTRESTO‐SAS trial whether sacubitril–valsartan could improve the outcome of SDB in CHF patients.
Source: ESC Heart Failure - Category: Cardiology Authors: Tags: Study Design Source Type: research